{"transactions":[{"id":727752,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T20:27:29.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":32000,"derivative":{"exercise_price":9.08,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001814338-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000181433826000004/ownership.xml","form_type":"4"}},{"id":744746,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-09T20:15:28.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2026 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date."}],"balance_after":16000,"derivative":{"exercise_price":6.04,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001814338-26-000002","document":"form4-06092026_040603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000181433826000002/form4-06092026_040603.xml","form_type":"4"}},{"id":839482,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:05:46.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":272243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."}],"balance_after":272243,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":272243},"source":{"system":"sec-edgar","filing":"0001193125-26-110759","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000119312526110759/ownership.xml","form_type":"4"}},{"id":839481,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T20:05:46.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":false,"shares":85045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."}],"balance_after":170092,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":85045},"source":{"system":"sec-edgar","filing":"0001193125-26-110759","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000119312526110759/ownership.xml","form_type":"4"}},{"id":839480,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2026-03-17T20:05:46.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":47029,"price":5.26,"value":247372.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the withholding by the Issuer of shares of Common Stock (based on $5.26 per share, the closing stock price on March 13, 2026) to satisfy tax withholding obligations associated with the vesting of RSUs and the consequent issuance of Common Stock."}],"balance_after":138767,"source":{"system":"sec-edgar","filing":"0001193125-26-110759","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000119312526110759/ownership.xml","form_type":"4"}},{"id":839479,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2026-03-17T20:05:46.000Z","date":"2026-03-13","kind":"exercise","planned":false,"acquired":true,"shares":85045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the acquisition of Common Stock from the vesting of one-third of the restricted stock units (\"RSUs\") granted on March 13, 2025."}],"balance_after":185796,"source":{"system":"sec-edgar","filing":"0001193125-26-110759","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000119312526110759/ownership.xml","form_type":"4"}},{"id":929290,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2026-01-28T21:05:10.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":false,"shares":55902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."}],"balance_after":55903,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":55902},"source":{"system":"sec-edgar","filing":"0001193125-26-027202","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000119312526027202/ownership.xml","form_type":"4"}},{"id":929289,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2026-01-28T21:05:10.000Z","date":"2026-01-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":22804,"price":6.82,"value":155523.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the withholding by the Issuer of shares of Common Stock (based on $6.82 per share, the closing stock price on January 27, 2026) to satisfy tax withholding obligations associated with the vesting of RSUs and the consequent issuance of Common Stock."}],"balance_after":100751,"source":{"system":"sec-edgar","filing":"0001193125-26-027202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000119312526027202/ownership.xml","form_type":"4"}},{"id":929288,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2026-01-28T21:05:10.000Z","date":"2026-01-27","kind":"exercise","planned":false,"acquired":true,"shares":55902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the acquisition of Common Stock from the vesting of one-third of the restricted stock units (\"RSUs\") granted on January 27, 2024."}],"balance_after":123555,"source":{"system":"sec-edgar","filing":"0001193125-26-027202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000119312526027202/ownership.xml","form_type":"4"}},{"id":1106407,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T12:33:20.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":4.94,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0000950170-25-087698","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000095017025087698/ownership.xml","form_type":"4"}},{"id":1118064,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T20:45:16.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 5, 2025 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":0.58,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-016288","document":"form4-06092025_040603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000141588925016288/form4-06092025_040603.xml","form_type":"4"}},{"id":1206502,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-14T21:03:32.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":255137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."}],"balance_after":255137,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":255137},"source":{"system":"sec-edgar","filing":"0000950170-25-039560","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017025039560/ownership.xml","form_type":"4"}},{"id":1292152,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2025-01-29T22:07:01.000Z","date":"2025-01-27","kind":"exercise","planned":false,"acquired":false,"shares":55902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"RSUs represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."}],"balance_after":111805,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":55902},"source":{"system":"sec-edgar","filing":"0000950170-25-010569","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017025010569/ownership.xml","form_type":"4"}},{"id":1292151,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2025-01-29T22:07:01.000Z","date":"2025-01-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":23644,"price":6.34,"value":149902.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the withholding by the Issuer of shares of Common Stock (based on $6.34 per share, the closing stock price on January 27, 2025) to satisfy tax withholding obligations associated with the vesting of RSUs and the consequent issuance of Common Stock."}],"balance_after":67653,"source":{"system":"sec-edgar","filing":"0000950170-25-010569","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017025010569/ownership.xml","form_type":"4"}},{"id":1292150,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2025-01-29T22:07:01.000Z","date":"2025-01-27","kind":"exercise","planned":false,"acquired":true,"shares":55902,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the acquisition of Common Stock from the vesting of one-third of the restricted stock units (\"RSUs\") granted on January 27, 2024."}],"balance_after":91297,"source":{"system":"sec-edgar","filing":"0000950170-25-010569","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017025010569/ownership.xml","form_type":"4"}},{"id":1380305,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2024-10-29T21:03:36.000Z","date":"2024-10-25","kind":"exercise","planned":false,"acquired":false,"shares":59288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"PSUs represent contingent rights to receive Common Stock on a one-for-one basis. These PSUs vest as follows: (a) one-third of these PSUs vest if, during any period of 90 consecutive trading days during the three-year period beginning on the grant date (the \"Performance Period\"), the Issuer's Common Stock closing stock price (plus the per share value of any dividends issued during the measurement date) (the \"Stock Price\") is at or above $7.00, (b) one-third of these PSUs vest, if during any period of 90 consecutive trading days during the Performance Period, the Stock Price is at or above $8.00, and (c) one-third of these PSUs vest, if during any 90 consecutive trading days during the Performance Period, the Stock Price is at or above $9.00. On March 12, 2024, the Board of Directors of the Issuer declared a special dividend of $0.60 per share of Common Stock, and each applicable Stock Price hurdle was lowered by $0.60 accordingly."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"PSUs represent contingent rights to receive Common Stock on a one-for-one basis. These PSUs vest as follows: (a) one-third of these PSUs vest if, during any period of 90 consecutive trading days during the three-year period beginning on the grant date (the \"Performance Period\"), the Issuer's Common Stock closing stock price (plus the per share value of any dividends issued during the measurement date) (the \"Stock Price\") is at or above $7.00, (b) one-third of these PSUs vest, if during any period of 90 consecutive trading days during the Performance Period, the Stock Price is at or above $8.00, and (c) one-third of these PSUs vest, if during any 90 consecutive trading days during the Performance Period, the Stock Price is at or above $9.00. On March 12, 2024, the Board of Directors of the Issuer declared a special dividend of $0.60 per share of Common Stock, and each applicable Stock Price hurdle was lowered by $0.60 accordingly."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"PSUs represent contingent rights to receive Common Stock on a one-for-one basis. These PSUs vest as follows: (a) one-third of these PSUs vest if, during any period of 90 consecutive trading days during the three-year period beginning on the grant date (the \"Performance Period\"), the Issuer's Common Stock closing stock price (plus the per share value of any dividends issued during the measurement date) (the \"Stock Price\") is at or above $7.00, (b) one-third of these PSUs vest, if during any period of 90 consecutive trading days during the Performance Period, the Stock Price is at or above $8.00, and (c) one-third of these PSUs vest, if during any 90 consecutive trading days during the Performance Period, the Stock Price is at or above $9.00. On March 12, 2024, the Board of Directors of the Issuer declared a special dividend of $0.60 per share of Common Stock, and each applicable Stock Price hurdle was lowered by $0.60 accordingly."}],"balance_after":118577,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":59288},"source":{"system":"sec-edgar","filing":"0000950170-24-118340","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017024118340/ownership.xml","form_type":"4"}},{"id":1380304,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2024-10-29T21:03:36.000Z","date":"2024-10-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":23893,"price":6.77,"value":161755.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the withholding by the Issuer of shares of Common Stock (based on $6.77 per share, the closing stock price on October 25, 2024) to satisfy tax withholding obligations associated with the vesting of PSUs and the consequent issuance of Common Stock."}],"balance_after":35395,"source":{"system":"sec-edgar","filing":"0000950170-24-118340","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017024118340/ownership.xml","form_type":"4"}},{"id":1380303,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $.0001 per share","published_at":"2024-10-29T21:03:36.000Z","date":"2024-10-25","kind":"exercise","planned":false,"acquired":true,"shares":59288,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the acquisition of Common Stock from the vesting of one-third of the performance stock units (\"PSUs\") granted on January 27, 2024 upon achieving the $7.00 share price target (adjusted for dividends paid)."}],"balance_after":59288,"source":{"system":"sec-edgar","filing":"0000950170-24-118340","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017024118340/ownership.xml","form_type":"4"}},{"id":1468183,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T12:40:54.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 26, 2025 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":5.71,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0000950170-24-078174","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000095017024078174/ownership.xml","form_type":"4"}},{"id":1487013,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T20:15:14.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 6, 2024 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":8.78,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-015960","document":"form4-06072024_040611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000141588924015960/form4-06072024_040611.xml","form_type":"4"}},{"id":1666875,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance Stock Units","published_at":"2024-01-30T22:04:04.000Z","date":"2024-01-27","kind":"grant","planned":false,"acquired":true,"shares":177865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Performance stock units (\"PSUs\") represent contingent rights to receive Common Stock on a one-for-one basis. These PSUs vest as follows: (a) one-third of these PSUs vest if, during any period of 90 consecutive trading days during the three-year period beginning on the grant date (the \"Performance Period\"), the Issuer's Common Stock closing stock price (plus the per share value of any dividends issued during the measurement date) (the \"Stock Price\") is at or above $7.00, (b) one-third of these PSUs vest, if during any period of 90 consecutive trading days during the Performance Period, the Stock Price is at or above $8.00, and (c) one-third of these PSUs vest, if during any 90 consecutive trading days during the Performance Period, the Stock Price is at or above $9.00."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Performance stock units (\"PSUs\") represent contingent rights to receive Common Stock on a one-for-one basis. These PSUs vest as follows: (a) one-third of these PSUs vest if, during any period of 90 consecutive trading days during the three-year period beginning on the grant date (the \"Performance Period\"), the Issuer's Common Stock closing stock price (plus the per share value of any dividends issued during the measurement date) (the \"Stock Price\") is at or above $7.00, (b) one-third of these PSUs vest, if during any period of 90 consecutive trading days during the Performance Period, the Stock Price is at or above $8.00, and (c) one-third of these PSUs vest, if during any 90 consecutive trading days during the Performance Period, the Stock Price is at or above $9.00."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Performance stock units (\"PSUs\") represent contingent rights to receive Common Stock on a one-for-one basis. These PSUs vest as follows: (a) one-third of these PSUs vest if, during any period of 90 consecutive trading days during the three-year period beginning on the grant date (the \"Performance Period\"), the Issuer's Common Stock closing stock price (plus the per share value of any dividends issued during the measurement date) (the \"Stock Price\") is at or above $7.00, (b) one-third of these PSUs vest, if during any period of 90 consecutive trading days during the Performance Period, the Stock Price is at or above $8.00, and (c) one-third of these PSUs vest, if during any 90 consecutive trading days during the Performance Period, the Stock Price is at or above $9.00."}],"balance_after":177865,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":177865},"source":{"system":"sec-edgar","filing":"0001209191-24-002427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919124002427/doc4.xml","form_type":"4"}},{"id":1666874,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-01-30T22:04:04.000Z","date":"2024-01-27","kind":"grant","planned":false,"acquired":true,"shares":167707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive Common Stock on a one-for-one basis. The RSUs vest over three years, one-third on each of the first three anniversaries of the date of grant."}],"balance_after":167707,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":167707},"source":{"system":"sec-edgar","filing":"0001209191-24-002427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919124002427/doc4.xml","form_type":"4"}},{"id":1666873,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-30T22:04:04.000Z","date":"2024-01-27","kind":"grant","planned":false,"acquired":true,"shares":219212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest over three years, one-third on each of the first three anniversaries of the date of grant."}],"balance_after":219212,"derivative":{"exercise_price":5.06,"expiration_date":"2034-01-27","underlying":"Common Stock, par value $.0001 per share","underlying_shares":219212},"source":{"system":"sec-edgar","filing":"0001209191-24-002427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919124002427/doc4.xml","form_type":"4"}},{"id":1666872,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2024-01-30T22:04:04.000Z","date":"2024-01-27","kind":"grant","planned":false,"acquired":true,"shares":109606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over two years, one-half on each of the first two anniversaries of the date of grant."}],"balance_after":109606,"derivative":{"exercise_price":5.06,"expiration_date":"2034-01-27","underlying":"Common Stock, par value $.0001 per share","underlying_shares":109606},"source":{"system":"sec-edgar","filing":"0001209191-24-002427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919124002427/doc4.xml","form_type":"4"}},{"id":1842067,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-29T13:00:17.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 28, 2024 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":1.22,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0001209191-23-040135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000120919123040135/doc4.xml","form_type":"4"}},{"id":1858951,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-12T13:03:21.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":10384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 8, 2023 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":10384,"derivative":{"exercise_price":5.7,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":10384},"source":{"system":"sec-edgar","filing":"0001209191-23-036147","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000120919123036147/doc4.xml","form_type":"4"}},{"id":2136457,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-17T20:45:01.000Z","date":"2022-10-13","kind":"grant","acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) October 13, 2023 or (ii) the date of the next Annual Meeting of Stockholders of the Company; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors of the Company or otherwise ceases to serve as a Director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":2.81,"expiration_date":"2032-10-13","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0001209191-22-053830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000120919122053830/doc4.xml","form_type":"4"}},{"id":2234278,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T20:16:39.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":10384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 9, 2022 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":10384,"derivative":{"exercise_price":2.15,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":10384},"source":{"system":"sec-edgar","filing":"0001209191-22-036293","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000120919122036293/doc4.xml","form_type":"4"}},{"id":2398411,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T01:31:38.000Z","date":"2021-07-26","kind":"grant","acquired":true,"shares":28480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in thirty-six equal monthly installments following July 26, 2021, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":28480,"derivative":{"exercise_price":8,"expiration_date":"2031-07-26","underlying":"Common Stock","underlying_shares":28480},"source":{"system":"sec-edgar","filing":"0000899243-22-006325","document":"doc5a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000089924322006325/doc5a.xml","form_type":"5/A","original_submission_date":"2022-02-14"}},{"id":2398412,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-14T21:43:01.000Z","date":"2021-07-26","kind":"grant","acquired":true,"shares":28840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in thirty-six equal monthly installments following July 26, 2021, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":28840,"derivative":{"exercise_price":8,"expiration_date":"2031-07-26","underlying":"Common Stock","underlying_shares":28840},"source":{"system":"sec-edgar","filing":"0000899243-22-006188","document":"doc5.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000089924322006188/doc5.xml","form_type":"5"}},{"id":2620159,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-03T00:11:51.000Z","date":"2021-07-29","kind":"purchase","acquired":true,"shares":10000,"price":8,"value":80000.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-21-031102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000089924321031102/doc4.xml","form_type":"4"}},{"id":2664080,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:35:07.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":8109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment\nis being file to accurately reflect the true number of options granted."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment\nis being file to accurately reflect the true number of options granted."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The original Form 4 filed on June 14, 2021 inadvertently listed the incorrect number of options granted to the Reporting Person. This amendment\nis being file to accurately reflect the true number of options granted."}],"balance_after":8109,"derivative":{"exercise_price":10.56,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":8109},"source":{"system":"sec-edgar","filing":"0001209191-21-041447","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000120919121041447/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-14"}},{"id":2670387,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T20:55:54.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in 12 equal monthly installments beginning on July 10, 2021 and, in any event, will be fully vested on the date of the next annual meeting of stockholders, subject to continued service as a director though the applicable vesting date."}],"balance_after":5834,"derivative":{"exercise_price":10.56,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0001209191-21-040264","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000120919121040264/doc4.xml","form_type":"4"}},{"id":3113619,"issuer":{"id":6823,"kind":"organization","name":"Verrica Pharmaceuticals Inc."},"owners":[{"id":35681,"kind":"person","name":"Nguyen Diem","position":1,"cik":"0001814338","reported_name":"Nguyen Diem","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T21:11:08.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":17502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the total shares subject to the option shall vest on June 9, 2021 and 1/36th of the total shares subject to the option shall vest monthly thereafter over the remaining two years of the vesting period, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":17502,"derivative":{"exercise_price":12.64,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":17502},"source":{"system":"sec-edgar","filing":"0001209191-20-035997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814338/000120919120035997/doc4.xml","form_type":"4"}}]}